Brief: Disc Reports Topline Results From Phase 2 Aurora Study Of Bitopertin In Patients With Erythropoietic Protoporphyria (EPP)

Disc Medicine

01/04/2024 13:52

April 1 (Reuters) - Disc Medicine Inc  IRON.O :
    * DISC REPORTS TOPLINE RESULTS FROM PHASE 2 AURORA STUDY OF
BITOPERTIN IN PATIENTS WITH ERYTHROPOIETIC PROTOPORPHYRIA (EPP)
    * DISC MEDICINE INC - STUDY MET PRIMARY ENDPOINT 
    * DISC MEDICINE: KEY SECONDARY ENDPOINT DID NOT MEET
STATISTICAL
SIGNIFICANCE VERSUS PLACEBO IN STUDY (ADDS DROPPED WORDS 'KEY
SECONDARY ENDPOINT')

Further company coverage:  IRON.O 

 ((Reuters.Briefs@thomsonreuters.com;))